Eli Lilly and Company

NAM - Neuroscience Account Manager Alzheimer-Demenz (m/w/d)

Germany

Not SpecifiedCompensation
Mid-level (3 to 4 years)Experience Level
Full TimeJob Type
UnknownVisa
Pharmaceuticals, HealthcareIndustries

Requirements

Candidates should possess a completed university degree in a relevant field such as Life Sciences, Pharmacy, Business Administration, or a related discipline. Several years of experience in pharmaceutical sales or marketing, particularly within the neurology or Alzheimer's disease area, are required. Strong knowledge of the German healthcare system and pharmaceutical regulations is essential.

Responsibilities

The Neuroscience Account Manager will be responsible for identifying and developing relationships with key stakeholders, including neurologists, clinics, and hospitals, to promote Lilly's neuroscience products. They will conduct sales presentations, manage accounts, and execute strategic account plans to drive sales growth. Furthermore, they will organize and lead educational events for medical professionals and contribute to the development and implementation of marketing strategies within their assigned territory.

Skills

Account Management
Neurology
Alzheimer's
Pharmaceutical Sales

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Key Metrics

Indianapolis, IndianaHeadquarters
1876Year Founded
$1,180.1MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.
Potential construction delays in Indiana could affect GLP-1 drug production timelines.
Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.
Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.
FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.
Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.
Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI